Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what support the Government is providing to projects working on a covid-19 vaccine.
The Government is supporting efforts to rapidly develop a coronavirus vaccine as soon as possible. This includes reviewing regulations and scaling up manufacturing, so that when a vaccine becomes available, it can be produced quickly and in large quantities. To date the UK government has secured early access to 340 million vaccines doses through agreements with six separate vaccine developers. This includes agreements with University of Oxford’s vaccine being developed with AstraZeneca and agreements with BioNTech/Pfizer alliance, Valneva, Novavax, Janssen and GSK/Sanofi Pasteur.
The Government has also taken action to ensure the country’s vaccine manufacturing capabilities are scaled up, so that if a vaccine is found to be effective it can be made available to the public as quickly as possible. The Government has announced a £93 million investment to open the UK’s first dedicated Vaccine Manufacturing and Innovation Centre, and an additional £38 million for a virtual centre of existing capability, in order to begin manufacturing at scale in the near future.